Reuters logo
BRIEF-bluebird bio And TC BioPharm Announce Strategic Collaboration
December 7, 2017 / 1:17 PM / in 4 days

BRIEF-bluebird bio And TC BioPharm Announce Strategic Collaboration

Dec 7 (Reuters) - bluebird bio Inc:

* BLUEBIRD BIO AND TC BIOPHARM ANNOUNCE STRATEGIC COLLABORATION TO RESEARCH AND DEVELOP GAMMA DELTA CAR T CELL PRODUCT CANDIDATES FOR CANCER IMMUNOTHERAPY

* BLUEBIRD BIO INC - FINANCIAL TERMS OF AGREEMENT INCLUDE A $16 MILLION UPFRONT PAYMENT

* BLUEBIRD BIO - FINANCIAL TERMS OF AGREEMENT ALSO INCLUDE POTENTIAL RESEARCH AND DEVELOPMENT, COMMERCIAL MILESTONE PAYMENTS

* BLUEBIRD BIO - AS PART OF DEAL, TC BIOPHARM ALSO ELIGIBLE TO GET UNDISCLOSED TIERED ROYALTIES ON PRODUCT SALES

* BLUEBIRD BIO INC - CO, TC BIOPHARM WILL WORK TOGETHER TO ADVANCE TC BIOPHARM‘S LEAD CAR-ENGINEERED GAMMA DELTA T CELL PROGRAM INTO CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below